Accenture buys strategy and consulting firm Bionest
Feb. 02, 2023 11:21 AM ETAccenture plc (ACN)By: Preeti Singh, SA News Editor
- Accenture (NYSE:ACN) has acquired strategy and consulting firm Bionest to expand its strategy capabilities in life sciences.
- Terms of the transaction were not disclosed.
- Headquartered in New York with a European office in Paris, Bionest's team of 46 scientifically-minded consultants, industry executives, and specialists will join Accenture Strategy in the Life Sciences practice.